4.7 Article

Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

Leo Swadling et al.

Summary: Research suggests that some individuals can clear potential SARS-CoV-2 infection after exposure, with T cells playing a role in the process. Studying healthcare workers who tested negative for antibodies revealed that they had stronger and more diverse memory T cells, with a focus on RTC.

NATURE (2022)

Article Immunology

An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Yanchun Peng et al.

Summary: Specific CD8(+) T cell responses targeting NP105-113-B*07:02 are associated with mild COVID-19 disease and high antiviral efficacy, providing potential targets for T cell vaccine design. These T cell responses show long-lasting preservation of antiviral functionality post-infection.

NATURE IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors

Daichao Wu et al.

Summary: This study reveals the structural information of SARS-CoV-2-specific T-cell receptors (TCRs) bound to their peptide-MHC targets and explains the mechanisms behind their selection of specific germline genes and recognition of different variants. This has important implications for designing vaccines to elicit pan-coronavirus immunity.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations

Stepan Nersisyan et al.

Summary: The T-cell COVID-19 Atlas is a comprehensive web portal that analyzes how SARS-CoV-2 mutations alter the presentation of viral peptides by HLA molecules. The findings highlight the importance of considering HLA allele diversity in predicting susceptibility to infection with virus variants.

NUCLEIC ACIDS RESEARCH (2022)

Article Hematology

Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India

R. Jain et al.

Summary: The objective of this study was to evaluate the seroprevalence of SARS-CoV-2 among recovered patients and analyze the reasons for deferral in potential convalescent plasma donors. The results showed that 87% of the recovered patients had IgG antibodies against SARS-CoV-2. The most common reason for deferral was the absence of IgG antibodies. The study also found that IgG antibodies against SARS-CoV-2 persist for a certain period and provide protection against reinfection.

TRANSFUSION CLINIQUE ET BIOLOGIQUE (2022)

Article Immunology

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde et al.

Summary: SARS-CoV-2-specific T cell epitopes were identified in convalescent and unexposed individuals, showing cross-reactivity with common cold coronaviruses. The diversity of SARS-CoV-2 T cell responses may be associated with mild symptoms of COVID-19.

NATURE IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Correlates of protection against SARS-CoV-2 in rhesus macaques

Katherine McMahan et al.

Summary: Adoptive transfer of purified IgG from convalescent macaques protects naive macaques against SARS-CoV-2 infection, and cellular immune responses contribute to protection against rechallenge with SARS-CoV-2. The findings suggest that relatively low antibody titres are sufficient for protection against SARS-CoV-2 in macaques, while higher antibody titres are required for treatment of SARS-CoV-2 infection.

NATURE (2021)

Article Medicine, General & Internal

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

S. F. Lumley et al.

Summary: In a longitudinal study of seropositive and seronegative health care workers undergoing asymptomatic and symptomatic SARS-CoV-2 testing, the presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Article Infectious Diseases

Performance of the T-SPOT© COVID test for detecting SARS-CoV-2-responsive T cells

Margaret Kruse et al.

Summary: The T-SPOT.COVID test showed high performance in identifying SARS-CoV-2-responsive T-cells, particularly during the 2-8 weeks after infection.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Cell Biology

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

Anthony T. Tan et al.

Summary: This study found that early induction of interferon-gamma (IFN-gamma) secreting SARS-CoV-2-specific T cells was present in patients with mild disease and accelerated viral clearance, while rapid induction and quantity of humoral responses were associated with an increase in disease severity. These findings highlight the importance of early functional SARS-CoV-2-specific T cells in both vaccine design and immune monitoring.

CELL REPORTS (2021)

Article Medicine, Research & Experimental

SARS-CoV-2 specific CD8+ T cell responses in convalescent COVID-19 individuals

Hassen Kared et al.

Summary: Characterization of T cell responses in convalescent individuals from SARS-CoV-2 infection revealed unique phenotypes and a coordinated immune response, with specific CD8(+) T cell responses directed against various epitopes from the virus proteome. The differentiation of T cells into stem cell and transitional memory subsets may be crucial for developing lasting protection against the virus.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Immunology

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection

Nina Le Bert et al.

Summary: The efficacy of virus-specific T cells in clearing pathogens involves a delicate balance between antiviral and inflammatory responses. Asymptomatic individuals clearing SARS-CoV-2 showed increased production of IFN-gamma and IL-2, along with a proportional secretion of IL-10 and proinflammatory cytokines, while symptomatic individuals displayed a disproportionate secretion of inflammatory cytokines triggered by SARS-CoV-2-specific T cell activation.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Multidisciplinary Sciences

An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses

Sara M. Mangsbo et al.

Summary: This study evaluated the specificity and sensitivity of a SARS-CoV-2 IFN-gamma Release Assay (IGRA) using commercially available and in-house designed peptide pools, finding that the in-house generated peptide pool had higher specificity. Sensitivity was higher in a cohort of previously hospitalized COVID-19 patients using the commercially available peptide pools.

PLOS ONE (2021)

Article Immunology

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

Jianmin Zuo et al.

Summary: The study shows that functional SARS-CoV-2-specific T cell responses are retained and robust at 6 months following infection, with higher T cell responses observed in donors who had experienced symptomatic infection. Levels of nucleoprotein-specific T cells were correlated with nucleoprotein-specific antibody levels, providing insights into the persistence and correlation of immune responses.

NATURE IMMUNOLOGY (2021)

Article Immunology

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses

Katie E. Lineburg et al.

Summary: Efforts are being made to understand the immune response to SARS-CoV-2, with a focus on T cell immunity and cross-recognition with seasonal coronaviruses. Research has shown that the N protein of SARS-CoV-2 induces an immunodominant response and T cells demonstrate cross-reactivity towards certain coronaviruses through specific peptide conformations.

IMMUNITY (2021)

Article Immunology

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity

Thi H. O. Nguyen et al.

Summary: This study characterized CD8(+) T cells specific for SARS-CoV-2 epitopes in COVID-19 patients and unexposed individuals, revealing that CD8(+) T cells specific for the immunodominant B7/N-105 epitope were detected at high frequencies both before and during acute COVID-19 and convalescence. The research also showed high naive precursor frequency and TCR alpha beta diversity within immunodominant B7/N-105-specific CD8(+) T cells, shedding light on the origins and responses of SARS-CoV-2-specific T cells.

IMMUNITY (2021)

Article Immunology

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers

Jean-Louis Bayart et al.

Summary: Data from this study showed a significant decline in antibodies levels at day 180 post SARS-CoV-2 vaccination, with a more pronounced decrease in neutralizing antibodies. The estimated half-life of IgG was around 21 days in seronegative individuals and 53 days in seropositive individuals, while the half-life of total antibodies ranged from 68 to 114 days. The decline in neutralizing antibodies was particularly stark, with around 45% of subjects testing negative at day 180.

VACCINES (2021)

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Article Cell Biology

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Tatjana Bilich et al.

Summary: The study found that antibody responses in COVID-19 convalescent individuals decreased or remained stable within 6 months, while T cell responses showed a robust increase. T cell responses included key epitopes that mediate long-term SARS-CoV-2 immunity.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features

Anastasia Gangaev et al.

Summary: This study identified a range of SARS-CoV-2 CD8(+) T cell responses across COVID-19 patients, including an epitope from ORF1ab with immunodominant features. The specific CD8(+) T cell responses can still be detectable up to 5 months after recovery from critical and severe disease, converting from dysfunctional effector cells to functional memory cells during convalescence.

NATURE COMMUNICATIONS (2021)

Article Immunology

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients

Sunil Kumar Saini et al.

Summary: This study experimentally evaluated MHC class I-binding peptides covering the complete SARS-CoV-2 genome, revealing significant CD8(+) T cell recognition of SARS-CoV-2 epitopes in patients with COVID-19, coupled with strong activation features in these T cells. Compared to healthy individuals, patients with severe disease displayed larger populations of SARS-CoV-2-specific T cells.

SCIENCE IMMUNOLOGY (2021)

Review Microbiology

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19

Alba Grifoni et al.

Summary: This review summarizes recent studies on SARS-CoV-2 T cell epitopes, highlighting the significant correlation between epitope number and antigen size. It also presents an analysis of 1,400 different reported SARS-CoV-2 epitopes and identifies discrete immunodominant regions of the virus and more prevalently recognized epitopes.

CELL HOST & MICROBE (2021)

Article Immunology

Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination

Mark M. Painter et al.

Summary: The study found that after SARS-CoV-2 mRNA vaccination, CD4(+) T cell responses in naïve individuals were fast, while CD8(+) T cell responses developed gradually. Th1 and Tfh cell responses after the first dose were correlated with post-boost CD8(+) T cells and neutralizing antibodies.

IMMUNITY (2021)

Article Cell Biology

SARS-CoV-2-specific CD8+ T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph

Louise C. Rowntree et al.

Summary: This study identified novel HLA-A*24:02-restricted epitopes of SARS-CoV-2 and characterized the CD8(+) T-cell responses associated with this HLA allomorph during COVID-19. The frequencies of A24/SARS-CoV-2-specific CD8(+) T cells increased substantially during COVID-19, showing effector and memory phenotypes. Ex vivo analyses of TCR alpha beta repertoires revealed distinct differences in repertoire diversity among COVID-19 patients for different epitopes.

IMMUNOLOGY AND CELL BIOLOGY (2021)

Article Multidisciplinary Sciences

Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

Lucie Loyal et al.

Summary: The study demonstrates that preexisting spike-cross-reactive T cells play a functional role in the immune response to SARS-CoV-2 infection and vaccination. Cross-reactive immunity may explain the rapid induction of immunity after primary SARS-CoV-2 immunization and the high rate of asymptomatic or mild COVID-19 cases.

SCIENCE (2021)

Article Microbiology

Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques

Kim J. Hasenkrug et al.

Summary: The study suggests that T cells are not critical for recovery from acute SARS-CoV-2 infections in rhesus macaques. Instead, B cell responses and antibodies are likely the essential mediators of protection from re-exposure.
Article Immunology

CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients

Vamsee Mallajosyula et al.

Summary: The study suggests that CD8(+) T cells with conserved specificities are more abundant in COVID-19 patients with mild disease, indicating a potential protective role.

SCIENCE IMMUNOLOGY (2021)

Article Cell Biology

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

Alison Tarke et al.

Summary: The study showed that SARS-CoV-2 variants do not significantly disrupt total T cell reactivity, although decreases in response frequency of 10%-22% were observed under certain assay/VOC combinations. This underscores the importance of actively monitoring T cell responses in the context of SARS-CoV-2 evolution.

CELL REPORTS MEDICINE (2021)

Article Cell Biology

Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform

Ahmed Abdul Quadeer et al.

Summary: This study provides a unified description and meta-analysis of SARS-CoV-2 T cell epitopes from recovered individuals, showing a broad diversity of epitopes largely unaffected by current variants. A set of 20 immunoprevalent epitopes inducing T cell responses in multiple cohorts have been identified. This information can guide immunological studies related to vaccines and diagnostics.

CELL REPORTS MEDICINE (2021)

Article Cell Biology

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

Alison Tarke et al.

Summary: By studying T cell responses in 99 convalescent COVID-19 cases, we identified various HLA-restricted epitopes derived from SARS-CoV-2 and observed distinct patterns of immunodominance. The epitopes were combined into megapools to facilitate the identification and quantification of virus-specific CD4(+) and CD8(+) T cells.

CELL REPORTS MEDICINE (2021)

Article Biochemistry & Molecular Biology

Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells

Isabel Schulien et al.

Summary: The study found that SARS-CoV-2 infection induces and forms functionally competent memory CD8(+) T cell responses, which can persist in some SARS-CoV-2 convalescent individuals. Even in the absence of virus-specific antibodies, these virus epitope-specific CD8(+) T cell responses are induced following infection.

NATURE MEDICINE (2021)

Article Medicine, Research & Experimental

Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals

Anthony T. Tan et al.

Summary: Defining the correlates of protection for managing the COVID-19 pandemic requires analysis of both antibody and T cell parameters. A simple and rapid SARS-CoV-2 spike protein-specific T cell test showed sensitivity comparable to traditional methods, and revealed similar T cell responses between vaccinees and convalescents, with individual responses showing wide heterogeneity in magnitude regardless of the time of analysis. Both humoral and cellular spike-specific immunity should be tested post-vaccination to evaluate current vaccine strategies.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Multidisciplinary Sciences

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Julian Braun et al.

NATURE (2020)

Article Multidisciplinary Sciences

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

Jose Mateus et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin et al.

NATURE (2020)

Article Medicine, General & Internal

Humoral Immune Response to SARS-CoV-2 in Iceland

Daniel F. Gudbjartsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

E. J. Anderson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype

Jennifer R. Habel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg et al.

SCIENCE (2020)

Article Medicine, Research & Experimental

Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia

Dyantha van der Lee et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Immunology

Improved methods for predicting peptide binding affinity to MHC class II molecules

Kamilla Kjaergaard Jensen et al.

IMMUNOLOGY (2018)

Review Gastroenterology & Hepatology

Adaptive immunity in HBV infection

Antonio Bertoletti et al.

JOURNAL OF HEPATOLOGY (2016)

Article Immunology

Cross-Reactivity of T Cells and Its Role in the Immune System

Galina Petrova et al.

CRITICAL REVIEWS IN IMMUNOLOGY (2013)